The Data Use Ontology to streamline responsible access to human biomedical datasets.
FAIR
GA4GH
automated data access
consent
controlled access
data access
data restrictions
ontology
secondary data use
standard
Journal
Cell genomics
ISSN: 2666-979X
Titre abrégé: Cell Genom
Pays: United States
ID NLM: 9918284260106676
Informations de publication
Date de publication:
10 Nov 2021
10 Nov 2021
Historique:
received:
28
02
2021
revised:
02
07
2021
accepted:
09
08
2021
entrez:
25
11
2021
pubmed:
26
11
2021
medline:
26
11
2021
Statut:
epublish
Résumé
Human biomedical datasets that are critical for research and clinical studies to benefit human health also often contain sensitive or potentially identifying information of individual participants. Thus, care must be taken when they are processed and made available to comply with ethical and regulatory frameworks and informed consent data conditions. To enable and streamline data access for these biomedical datasets, the Global Alliance for Genomics and Health (GA4GH) Data Use and Researcher Identities (DURI) work stream developed and approved the Data Use Ontology (DUO) standard. DUO is a hierarchical vocabulary of human and machine-readable data use terms that consistently and unambiguously represents a dataset's allowable data uses. DUO has been implemented by major international stakeholders such as the Broad and Sanger Institutes and is currently used in annotation of over 200,000 datasets worldwide. Using DUO in data management and access facilitates researchers' discovery and access of relevant datasets. DUO annotations increase the FAIRness of datasets and support data linkages using common data use profiles when integrating the data for secondary analyses. DUO is implemented in the Web Ontology Language (OWL) and, to increase community awareness and engagement, hosted in an open, centralized GitHub repository. DUO, together with the GA4GH Passport standard, offers a new, efficient, and streamlined data authorization and access framework that has enabled increased sharing of biomedical datasets worldwide.
Identifiants
pubmed: 34820659
doi: 10.1016/j.xgen.2021.100028
pii: S2666-979X(21)00035-5
pmc: PMC8591903
doi:
Types de publication
Journal Article
Langues
eng
Pagination
NoneSubventions
Organisme : NHGRI NIH HHS
ID : U24 HG006941
Pays : United States
Organisme : NIH HHS
ID : R24 OD011883
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG010262
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : RM1 HG010860
Pays : United States
Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
M.N.C. is an employee of Foundation Medicine and equity holder of Roche. A.A.P. is a venture partner at GV and an employee of alphabet corporation. He has received funding from MSFT, Verily, IBM, Intel, Bayer, and Novartis. The views expressed by L.L.R. are the author’s own and do not necessarily represent those of her organization.
Références
Cell Genom. 2021 Nov 10;1(2):
pubmed: 35072136
Nat Biotechnol. 2007 Nov;25(11):1251-5
pubmed: 17989687
Stud Health Technol Inform. 2004;102:20-38
pubmed: 15853262
Nat Genet. 2015 Jul;47(7):692-5
pubmed: 26111507
Nature. 2021 Feb;590(7845):198-201
pubmed: 33568833
Cell Genom. 2021 Nov 10;1(2):
pubmed: 35128509
Nat Genet. 2018 Apr;50(4):474-476
pubmed: 29632381
Cell Genom. 2021 Nov 10;1(2):None
pubmed: 34820660
PLoS Genet. 2016 Jan 21;12(1):e1005772
pubmed: 26796797
Nucleic Acids Res. 2014 Jan;42(Database issue):D975-9
pubmed: 24297256
NPJ Genom Med. 2018 Jul 23;3:17
pubmed: 30062047
Nucleic Acids Res. 2020 Jan 8;48(D1):D704-D715
pubmed: 31701156
J Law Biosci. 2020 Aug 19;7(1):lsaa065
pubmed: 33005429
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244